Newsletters — 1996

Download as PDF file (N/A)


News from the California Breast Cancer Research Program – Volume 2, Number 1, Autumn 1996

BCRP: Who We Are and What We Do

The California Breast Cancer Research Program (BCRP) was created by the California Breast Cancer Act of 1993, sponsored by Assemblywoman Barbara Friedman. The Act and enabling legislation increased the cigarette tax by two cents per pack and allocated 45% of the revenue to BCRP to fund research on the cause, prevention, detection and cure of breast cancer. Managed by the University of California, the state's official research arm, BCRP is one of the Special Research Programs that are administratively housed in the Office of the President, Health Affairs. The staff manages all programmatic and fiscal aspects of the grant process, aided by other units within the Office of the President. Strategies, goals and oversight are provided by an external advisory board, the Breast Cancer Research Council.

BCRP's Funding Cycle III Call for Applications

BCRP, now entering its third grant cycle, is soliciting applications from investigators seeking funding for breast cancer research. Three new award mechanisms, developed for this cycle, as well as several previously available award types, are being offered.

Topic-Specific Requests for Applications (RFAs) New in this cycle are two topic-specific Requests for Applications (RFAs).

The Basic Breast Biology RFA solicits applications for research into previously unknown aspects of breast development, physiology or biochemistry that may provide insights into new approaches to prevent, detect or treat breast cancer and/or insights into individual differences in breast cancer initiation and/or rate of progression.

The Prevention, Risk Identification and Risk Modification RFA solicits applications to explore and define the differences between women who have breast cancer and those who do not, and the factors to which these differences may be attributed. This especially includes investigation into factors about which there is general concern, but no firmly established evidence.

The Community-Initiated Research Collaboration (CIRC) The purpose of this newly-developed award is to stimulate and support collaborations between community members or organizations and experienced research scientists to perform scientifically rigorous research into breast cancer-related problems that: are identified as important by specific communities in the state; are likely to produce results that are meaningful to specific communities; and use methods that are relevant, culturally sensitive, and appropriate to the interested communities. Offered in Cycle III is the CIRC Pilot Award, which is intended to support the development of appropriate collaborations and the initial phase of a project. Awardees are expected to compete in Cycle IV for a full CIRC Research Award, which will provide up to $500,000 to pursue the research planned and initiated with the Pilot Award.

The Translational Research Collaboration (TRC) This award is intended to encourage inter- and intra-institutional commitment to innovative, translational research utilizing a cross-disciplinary approach. The award will fund projects whose work is aimed at translating research from epidemiologic, social/behavioral, laboratory or clinical studies into the health care and lay communities through a synergy of several scientific disciplines and/or organizations. The thrust of the TRC is to encourage team-building that might, for example, involve biochemists, sociologists, medical anthropologists and social psychologists. Combinations of academic, industry and health care communities are especially encouraged. As in the above award, a Pilot Grant is being offered in Cycle III to support the development of the collaboration and the initial phase of a project, while a full TRC Research Award of up to $500,000 will be offered in Cycle IV.

For other Priority Areas and Funding Mechanisms, please see the Call for Applications, available on our WWW Home Page or upon request from the BCRP office.